Skip to main content
AAN.com
Brief Communications
April 25, 2000

Detection of ventricular enlargement in patients at the earliest clinical stage of MS

April 25, 2000 issue
54 (8) 1689-1691

Abstract

Article abstract The aim of this study was to determine whether atrophy could be detected at the earliest clinical stages of MS. Patients were selected from a 1-year follow-up MRI study of clinically isolated syndromes. Nine patients who developed MS were compared with eight matched patients who had no further symptoms. Significant ventricular enlargement occurred in the group that developed MS but not in the other group. Our findings show that atrophy, albeit mild, can be detected early in the course of MS.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Gross KR, Tomberg TA, Kokk AA, Kaasik AE. The prognosis of multiple sclerosis: computed tomographic comparisons. Zh Nevropatol Psikhiatr Im S S Korsakova 1993;93:32–35.
2.
Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 1995;118:1583–1592.
3.
Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD. Three-dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;66:323–330.
4.
Losseff NA, Wang L, Lai M, et al. Progressive cerebral atrophy in multiple sclerosis. A serial study. Brain 1996;119:2009–2019.
5.
Filippi M, Colombo B, Rovaris M, Pereira C, Martinelli V, Comi G. A longitudinal magnetic resonance imaging study of the cervical cord in multiple sclerosis. J Neuroimaging 1997;7:78–80.
6.
Losseff NA, Webb SL, O’Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701–708.
7.
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285.
8.
Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53:15–25.
9.
O’Riordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998;121:495–503.
10.
Brex PA, Gomez-Anson B, Parker GJM, et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 1999;166:16–22.

Information & Authors

Information

Published In

Neurology®
Volume 54Number 8April 25, 2000
Pages: 1689-1691

Publication History

Received: October 26, 1999
Accepted: January 12, 2000
Published online: April 25, 2000
Published in print: April 25, 2000

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

P.A. Brex, MRCP
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
R. Jenkins, BSc
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
N.C. Fox, MRCP
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
W.R. Crum, DPhil
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
J.I. O’Riordan, MRCP
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
G.T. Plant, FRCP
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.
D.H. Miller, FRCP
From the NMR Research Unit (Drs. BrexO’Riordan, and Miller) and the Dementia Research Group (Drs. Fox and Crum, and R. Jenkins), Institute of Neurology, University College London; and Moorfields Eye Hospital (Dr. Plant), London, UK.

Notes

Address correspondence and reprint requests to Professor D.H. Miller, NMR Research Group, 6th floor, Institute of Neurology, Queen Square, London WC1N 3BG, UK; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis, Neurology, 63, 11_suppl_5, (S3-S11), (2023)./doi/10.1212/WNL.63.11_suppl_5.S3
    Abstract
  2. MRI in the diagnosis and management of multiple sclerosis, Neurology, 58, 8_suppl_4, (S23-S31), (2023)./doi/10.1212/WNL.58.8_suppl_4.S23
    Abstract
  3. Optimizing the association between disability and biological markers in MS, Neurology, 57, 7, (1253-1258), (2023)./doi/10.1212/WNL.57.7.1253
    Abstract
  4. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS, Neurology, 57, 7, (1239-1247), (2023)./doi/10.1212/WNL.57.7.1239
    Abstract
  5. 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis, Neurology, 57, 4, (722-724), (2023)./doi/10.1212/WNL.57.4.722
    Abstract
  6. Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution, Neurology, 65, 10, (1626-1630), (2023)./doi/10.1212/01.wnl.0000184493.06254.a6
    Abstract
  7. Evidence of early cortical atrophy in MS, Neurology, 60, 7, (1157-1162), (2023)./doi/10.1212/01.WNL.0000055926.69643.03
    Abstract
  8. Eight-year follow-up study of brain atrophy in patients with MS, Neurology, 59, 9, (1412-1420), (2023)./doi/10.1212/01.WNL.0000036271.49066.06
    Abstract
  9. Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis, Frontiers in Molecular Neuroscience, 15, (2022).https://doi.org/10.3389/fnmol.2022.1024058
    Crossref
  10. Linear brain atrophy measures in multiple sclerosis and clinically isolated syndromes: a 30-year follow-up, Journal of Neurology, Neurosurgery & Psychiatry, 92, 8, (839-846), (2021).https://doi.org/10.1136/jnnp-2020-325421
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share